544 related articles for article (PubMed ID: 38098067)
21. Are We What We Eat? Impact of Diet on the Gut-Brain Axis in Parkinson's Disease.
Alfonsetti M; Castelli V; d'Angelo M
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057561
[TBL] [Abstract][Full Text] [Related]
22. Disease mechanisms as subtypes: Microbiome.
Bonvegna S; Cilia R
Handb Clin Neurol; 2023; 193():107-131. PubMed ID: 36803806
[TBL] [Abstract][Full Text] [Related]
23. Brain-gut-microbiota axis in Parkinson's disease.
Mulak A; Bonaz B
World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
[TBL] [Abstract][Full Text] [Related]
24. Exploring the multifactorial aspects of Gut Microbiome in Parkinson's Disease.
Pavan S; Prabhu AN; Prasad Gorthi S; Das B; Mutreja A; Shetty V; Ramamurthy T; Ballal M
Folia Microbiol (Praha); 2022 Oct; 67(5):693-706. PubMed ID: 35583791
[TBL] [Abstract][Full Text] [Related]
25. Gut brain axis: an insight into microbiota role in Parkinson's disease.
Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
[TBL] [Abstract][Full Text] [Related]
26. Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.
Metta V; Leta V; Mrudula KR; Prashanth LK; Goyal V; Borgohain R; Chung-Faye G; Chaudhuri KR
J Neurol; 2022 Mar; 269(3):1154-1163. PubMed ID: 33881598
[TBL] [Abstract][Full Text] [Related]
27. Emerging insights between gut microbiome dysbiosis and Parkinson's disease: Pathogenic and clinical relevance.
Bi M; Feng L; He J; Liu C; Wang Y; Jiang H; Liu SJ
Ageing Res Rev; 2022 Dec; 82():101759. PubMed ID: 36243356
[TBL] [Abstract][Full Text] [Related]
28. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease.
Zheng SY; Li HX; Xu RC; Miao WT; Dai MY; Ding ST; Liu HD
Ageing Res Rev; 2021 Aug; 69():101347. PubMed ID: 33905953
[TBL] [Abstract][Full Text] [Related]
29. Is Gut Dysbiosis an Epicenter of Parkinson's Disease?
Rajput C; Sarkar A; Sachan N; Rawat N; Singh MP
Neurochem Res; 2021 Mar; 46(3):425-438. PubMed ID: 33400024
[TBL] [Abstract][Full Text] [Related]
30. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
Campos-Acuña J; Elgueta D; Pacheco R
Front Immunol; 2019; 10():239. PubMed ID: 30828335
[TBL] [Abstract][Full Text] [Related]
31. Oral and intestinal dysbiosis in Parkinson's disease.
Berthouzoz E; Lazarevic V; Zekeridou A; Castro M; Debove I; Aybek S; Schrenzel J; Burkhard PR; Fleury V
Rev Neurol (Paris); 2023 Nov; 179(9):937-946. PubMed ID: 36934020
[TBL] [Abstract][Full Text] [Related]
32. New hope for Parkinson's disease treatment: Targeting gut microbiota.
Fan HX; Sheng S; Zhang F
CNS Neurosci Ther; 2022 Nov; 28(11):1675-1688. PubMed ID: 35822696
[TBL] [Abstract][Full Text] [Related]
33. The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment.
Varesi A; Campagnoli LIM; Fahmideh F; Pierella E; Romeo M; Ricevuti G; Nicoletta M; Chirumbolo S; Pascale A
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293176
[TBL] [Abstract][Full Text] [Related]
34. [The role of the gut microbiota in Parkinson's disease].
Verugina NI; Levin OS; Lyashenko EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(10. Vyp. 2):86-91. PubMed ID: 34870920
[TBL] [Abstract][Full Text] [Related]
35. The Gut and Parkinson's Disease: Hype or Hope?
Scheperjans F; Derkinderen P; Borghammer P
J Parkinsons Dis; 2018; 8(s1):S31-S39. PubMed ID: 30584161
[TBL] [Abstract][Full Text] [Related]
36. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease.
Kaur G; Behl T; Bungau S; Kumar A; Uddin MS; Mehta V; Zengin G; Mathew B; Shah MA; Arora S
Curr Neuropharmacol; 2021; 19(2):233-247. PubMed ID: 32504503
[TBL] [Abstract][Full Text] [Related]
37. Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment.
Salim S; Ahmad F; Banu A; Mohammad F
J Adv Res; 2023 Aug; 50():83-105. PubMed ID: 36332796
[TBL] [Abstract][Full Text] [Related]
38. Parkinson's disease and the gastrointestinal microbiome.
Lubomski M; Tan AH; Lim SY; Holmes AJ; Davis RL; Sue CM
J Neurol; 2020 Sep; 267(9):2507-2523. PubMed ID: 31041582
[TBL] [Abstract][Full Text] [Related]
39. Gut Microbiota: A Novel Therapeutic Target for Parkinson's Disease.
Zhu M; Liu X; Ye Y; Yan X; Cheng Y; Zhao L; Chen F; Ling Z
Front Immunol; 2022; 13():937555. PubMed ID: 35812394
[TBL] [Abstract][Full Text] [Related]
40. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
